Performance Target. (i) Subject to the Participant’s continued employment or service with the Company, a specified percentage of the RSUs shall vest if both (A) the Participant remains in continuous employment or continuous service with the Company on [END YEAR], and (B) the Company achieves EPS growth (as measured by the extent to which the Company’s EPS for fiscal [END YEAR] exceeds the Company’s EPS for fiscal [BEGINNING YEAR]) equal to or in excess of the amounts set forth on Exhibit A (the “Performance Target”). Unless provided otherwise by the Committee, the Participant shall be deemed to not be in continuous employment or continuous service if the Participant’s status changes from employee to non-employee, or vice-versa. The actual number of RSUs that may vest may range from zero to 200% of the Target Amount based on the extent to which the Performance Target is achieved, in accordance with the methodology set out on Exhibit A. If the Company does not achieve the minimum Performance Target as set out on Exhibit A, then no RSUs shall vest and all RSUs shall be cancelled in their entirety and no vesting shall occur unless and until the Committee certifies that the Performance Target has been met (the “Certification”).
Performance Target. Except as otherwise provided in Section 3(f)(iii) hereof, in the event that the "Performance Target" set forth in Exhibit A to the minutes of the March 11, 1999 meeting of the Compensation Committee of Employer's Board shall not have been achieved by the Company, then upon written notice referencing this Section 3(g) given by the Board to Executive at any time during the sixty day period commencing March 31, 2000, (i) Section 1 hereof shall be amended by replacing the date AMarch 31, 2003" with the date "Xxxxx 00, 0000", (xx) Section 3(a) hereof shall be amended by deleting the words Athe Salary shall be increased to $515,000" and the words "beginning April 1, 2001" from the proviso therein (iii) Section 3(d) hereof shall be amended by deleting clause (ii) thereof and re-numbering the remaining clauses of said Section accordingly; and (iv) Section 3(f) hereof shall be amended by deleting clause (i) thereof and re-numbering the remaining clauses of said Section accordingly.
Performance Target. The critical performance target is the achievement of a 20 percent reduction in a 30-day all-cause readmission rate over the term of this agreement. CMS will take into consideration the following primary outcome measures when evaluating performance: 20 percent reduction in a 30-day all cause readmission rate for total fee-for service population across all partner hospitals as compared to baseline.
Performance Target. The Founder Parties hereby covenant to the following performance targets for the Group Companies on a consolidated basis under GAAP: (i) no net loss is recorded for the fourth quarter (Q4) of 2018 (the “2018 Performance Target”); and (ii) the revenue growth for the calendar year of 2019 is 10% or higher compared to revenues in calendar year 2018, and the net profits exceed US$1,500,000 during calendar year of 2019 (the “2019 Performance Target”). If the Group Companies failed to reach the 2018 Performance Target, the Founder Parties shall refrain from exercising any portion of the Annual Sales Quota. If, however, the Group Companies reached the above 2019 Performance Target, regardless whether the Group Companies reached the above 2018 Performance Target, the Founder Parties shall be entitled to exercise the Annual Sales Quota accumulated after the Conversion through the date of confirmation of the 2019 Performance Target. Furthermore, if the Group Companies continued to fail to reach the above 2018 and 2019 Performance Targets, the Founder Parties shall refrain from exercising any portion of the Annual Sales Quota (i.e. 1/3 of the Issued ADSs), unless during the following year (i.e. the calendar year of 2020), the Group Companies see growth in revenue and net profits respectively of at least 10% based on the previous target (which shall mean that the net profits exceeded US$1,650,000) (the “2020 Performance Target”), in which case the Founder Parties shall no longer be subject to any Annual Sales Quota after calendar year 2020. For avoidance of doubt, the Founder Parties are entitled to sell 100% of their ADSs if the 2020 Performance Target is reached, subject to compliance with the limitations on sale under Rule 144 of the Securities Act. If, however, the Group Companies failed to reach the 2020 Performance Target, thereafter the Group Companies shall be subject to a performance target further increased in a similar manner, and the Founder Parties shall continue to refrain from exercising any portion of the Annual Sales Quota.
Performance Target. The term “Performance Target” shall mean, (i) with respect to fiscal year 2008, 2009 or 2010, 85% of the Targeted EBITDA for such fiscal year as set forth in Exhibit A hereto, and (ii) with respect to any fiscal year ending on or after December 31, 2011, the greater of (x) 85% of the Targeted EBITDA as set forth the Company’s annual plan for such fiscal year, as such plan is approved by the Board in good faith or (y) $163 million; provided, that the Performance Target as of the end of any fiscal quarter shall be equal to the Performance Target for the entire fiscal year prorated on a quarterly basis through the end of such fiscal quarter.
Performance Target. (i) Satisfaction of the Performance Target during any of the Vesting Periods described in (a) above shall require that the Company remain in compliance during the entire fiscal period immediately prior to each respective vesting date with the all of the financial covenants contained in each of the Company’s senior credit facility agreements with each of the Company’s senior secured lenders. In that regard, the financial covenants that shall be required to be met during any fiscal period shall be those contained in the credit facility agreements then in effect, so long as any modifications to such covenants are approved by the Company’s Board of Directors (“Board”) in connection with the approval of any amendment to the Company’s existing credit facility agreements or the adoption of new credit facility agreements that replace the Company’s existing credit facility agreements. Waivers of covenant compliance by the Company’s lenders for any period covered by this Agreement shall constitute satisfaction of such covenants for purposes of this Section 2(b).